Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study
Authors:
- 1 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 74, 86-91
Abstract
Background: Existing staging systems for pancreatic neuroendocrine neoplasms only provide accuracy in stratifying disease severity without enough sensitivity in prognosis predicting. Previously presented models mainly set overall survival as endpoint but ignore the importance of recurrence. Methods: Univariate and multivariate analyses were retrospectively conducted on the potential prognostic factors of 245 patients who underwent curable surgery of G1/2 pancreatic neuroendocrine tumors from December 2002 to May 2018 in our institute. Proposed model based on statistically significant factors were tested for recurrence risk classification estimation validity as measured by discrimination (receiver operator characteristic [ROC] curve and Harrell's c-index [HCI]) and calibration. Results: Multivariate analyses found lymph node metastasis, larger tumor size and grade 2 independent risk factors of disease-free survival (DFS). The novel scoring system for recurrence risk classification sorted patients into three groups: score < 15.4 for low risk (79.0%, 3- and 5-year recurrence risk 0.8% and 4.3%, median DFS not reached), score > 15.4, < 24.5 for intermediate risk (20.8%, 3- and 5-year recurrence risk 11.6% and 21.4%, median DFS 70 months) and score > 24.5 for high risk (10.2%, 3- and 5-year recurrence risk 37.3% and 68.7%, median DFS 49 months).The area under curve (AUC) and HCI of our system were 0.871 and 0.929, superior to those of European Neuroendocrine Tumor Society (AUC 0.833, HCI 0.806). Conclusion: The presented system can be utilized to identify G1/2 pancreatic neuroendocrine tumors patients with high recurrence risk, which might be appropriate for peri-operative adjuvant therapy.Keywords
This publication has 29 references indexed in Scilit:
- Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasmsSurgery, 2012
- Prognostic Factors and Characteristics of Pancreatic Neuroendocrine Tumors: Single Center ExperienceYonsei Medical Journal, 2012
- Surgical Treatment of Sporadic Pancreatic Neuroendocrine Tumors: A State of the Art ReviewThe Scientific World Journal, 2012
- Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumorSurgery, 2011
- Surgical Treatment of Pancreatic Neuroendocrine Tumors: Report of 112 CasesDigestive Surgery, 2010
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsLaboratory Investigation, 2010
- Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumoursAnnals of Oncology, 2008
- Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?Journal of Clinical Oncology, 2007
- Well-Differentiated Pancreatic Nonfunctioning Tumors/CarcinomaNeuroendocrinology, 2006
- Dose-Response and Trend Analysis in EpidemiologyEpidemiology, 1995